RESUMO
This work describes the synthesis and characterization of new apatite phases co-doped with gallium, magnesium and carbonate, exhibiting osteogenic and antibacterial ability. The apatites are synthesized at low temperature to retain nanocrystallinity and controlled doping with the various bioactive foreign ions, as assessed by physico-chemical and crystallographic analyses, reporting the achievement of single phases with reduced crystal ordering. The analysis of single and multi-doped apatites reports to different mechanisms acting in the incorporation of gallium and magnesium ions in the apatite structure. The release of bioactive ions is correlated to the behavior of human mesenchymal stem cells and of different bacterial strands, selected among the most frequently affecting surgical procedures. Enhanced osteogenic and antibacterial ability is assessed in multi-doped apatites, thus suggesting potential future applications as new smart biomaterials integrating a significant boosting of bone regeneration with adequate protection against bacteria. © 2017 Wiley Periodicals Inc. J Biomed Mater Res Part A: 106A: 521-530, 2018.
Assuntos
Antibacterianos/farmacologia , Durapatita/farmacologia , Nanopartículas/química , Osteogênese , Tecido Adiposo/citologia , Fosfatase Alcalina/genética , Fosfatase Alcalina/metabolismo , Bactérias/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Forma Celular/efeitos dos fármacos , Fenômenos Químicos , Durapatita/química , Humanos , Íons , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/efeitos dos fármacos , Células-Tronco Mesenquimais/enzimologia , Testes de Sensibilidade Microbiana , Osteogênese/efeitos dos fármacos , Espectroscopia de Infravermelho com Transformada de Fourier , Difração de Raios XRESUMO
The impact of polymicrobial bacterial infection on chronic wounds has been studied extensively, but standard bacteriological analysis is not always sensitive enough. Molecular approaches represent a promising alternative to the standard bacteriological analysis. This work aimed to assess the usefulness of a panbacterial quantitative real-time PCR reaction to quantitate the total bacterial load in chronic wounds treated with Cutimed™ Sorbact™, a novel therapeutic approach based on hydrophobic binding of bacteria to a membrane. The results obtained by panbacterial real-time PCR on conserved sequences of the bacterial 16S gene show that the bacterial burden significantly decreased in 10 out of 15 healing chronic wounds, and did not change in 5 out of 5 non-healing chronic wounds. On the contrary, classical culture for S. aureus and P. aeruginosa, and real-time PCR for Bacteroides and Fusobacterium did not show any correlation with the clinical outcome. Our study also shows that quantification of chronic wounds by panbacterial real-time PCR is to be performed on biopsies and not on swabs. These results show that panbacterial real-time PCR is a promising and quick method of determining the total bacterial load in chronic wounds, and suggest that it might be an important biomarker for the prognosis of chronic wounds under treatment.
Assuntos
Bactérias/classificação , Bactérias/isolamento & purificação , Técnicas Bacteriológicas/métodos , Coinfecção/microbiologia , Reação em Cadeia da Polimerase em Tempo Real/métodos , Infecção dos Ferimentos/microbiologia , Bactérias/genética , Coinfecção/terapia , Método Duplo-Cego , Humanos , Projetos Piloto , RNA Ribossômico 16S/genética , Resultado do Tratamento , Infecção dos Ferimentos/terapiaRESUMO
Intramuscularly (i.m.) delivered plasmid DNA encoding a secreted form of glycoprotein B of herpes simplex virus type 1 (HSV-1 gB1s) was evaluated for the ability to elicit a protective immune response in Balb/c mice. Animals received three i.m. injections of a gB1s expression plasmid (pRP-RSV-gB1s) or of a wild-type transmembrane gB1 coding plasmid (pRP-RSV-gB1), while control mice were injected with the vector alone (pRP-RSV). A specific antibody response was observed in almost all immunized animals, and in most cases antibodies were also detected after 1 month in the absence of further vaccine boosts. Serum antibodies mostly displayed neutralizing activity against HSV-1. Glycoprotein B1s DNA immunization was also effective in protecting animals against the primary infection induced by a subsequent HSV-1 challenge and limited HSV-1 infection of sensitive ganglia.
Assuntos
DNA Viral/imunologia , Herpes Simples/virologia , Simplexvirus/imunologia , Vacinas de DNA/administração & dosagem , Proteínas do Envelope Viral/imunologia , Animais , Anticorpos Antivirais/sangue , DNA Viral/análise , Feminino , Gânglios Espinais/virologia , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Testes de Neutralização , Plasmídeos/imunologia , Reação em Cadeia da Polimerase , Vacinação , Proteínas do Envelope Viral/genética , Latência ViralRESUMO
A secreted form of gB1 (gB1s), previously shown to protect rabbits against HSV-1 ocular infection when inoculated systemically, was delivered to rabbit periocular area to evaluate its vaccine efficacy upon local administration. The efficacy of local or systemic inoculation of a gB1s-DNA-based vaccine in the rabbit model of ocular HSV-1 infection was assessed in parallel flow. Rabbits received four inoculations of the different immunogens, then immune responses and clinical symptoms were evaluated. Both the local protein and the systemic DNA administration elicited a neutralizing antibody response, reduced ocular symptoms with respect to controls (P<0.01), and completely prevented the death of rabbits from encephalitis. Conversely, local DNA vaccination did not induce any detectable antibody response, and could only partially protect rabbits from the development of encephalitis and severe ocular infection.
Assuntos
Herpesvirus Humano 1/imunologia , Vacinas contra Herpesvirus/imunologia , Ceratite Herpética/prevenção & controle , Vacinas de DNA/imunologia , Proteínas do Envelope Viral/imunologia , Animais , Anticorpos Antivirais/biossíntese , Ensaio de Imunoadsorção Enzimática , Masculino , Coelhos , Vacinas de DNA/administração & dosagemRESUMO
Intramuscular immunization of mice with plasmids encoding two transdominant negative mutants of the HIV-1 Tat protein (Tat22 and Tat22/37) elicited a humoral response to wild-type Tat that is comparable to that induced by inoculation of wild-type tat DNA or Tat protein. The percentage of the responders and the Ab titers continued to increase after three additional DNA boosts and pretreatment with bupivacaine at the site of inoculation, without a significant difference (p > 0.05) among the three groups of mice immunized with mutant and wild-type tat genes. By utilizing synthetic peptides representing the amino acid sequence of Tat, one major B cell epitope was defined within the cysteine-rich domain of Tat. Anti-Tat IgG Abs directed against this epitope were found in mice immunized with all tat DNA constructs, whereas different Tat epitopes were detected in mice immunized with the Tat protein. Similarly, IgG2a was the predominant isotype in DNA-immunized mice, with both mutants and wild-type tat genes, as compared with protein immunization, which induced mostly IgG1 and IgG3. Sera from most immunized mice neutralized the effect of extracellular Tat in activating HIV-1 replication. A cellular response was also elicited as indicated by the proliferation of splenocytes when stimulated with wild-type Tat. These results indicate that the wild-type Tat Ag is recognized by Abs and T cells induced by DNA immunization with mutated tat genes, suggesting the possible use of these Tat transdominant mutants, lacking viral trans activation activity and capable of blocking wild-type Tat activity, in the development of an anti-HIV-1 vaccine.
Assuntos
Anticorpos Antivirais/biossíntese , Produtos do Gene tat/imunologia , Genes tat/imunologia , HIV-1/imunologia , Mutagênese Sítio-Dirigida/imunologia , Ativação Transcricional/imunologia , Vacinas de DNA/imunologia , Células 3T3 , Animais , Anticorpos Bloqueadores/farmacologia , Epitopos/imunologia , Feminino , Vetores Genéticos/administração & dosagem , Vetores Genéticos/síntese química , Vetores Genéticos/imunologia , HIV-1/genética , Humanos , Soros Imunes/farmacologia , Imunidade Celular , Injeções Intramusculares , Células Jurkat , Ativação Linfocitária/genética , Camundongos , Camundongos Endogâmicos BALB C , Vacinas de DNA/síntese química , Replicação Viral/imunologia , Produtos do Gene tat do Vírus da Imunodeficiência HumanaRESUMO
A series of retroviral vectors with potential anti-tat and antirev activity was developed. Vectors containing a tat transdominant negative mutant (tat22/37) and an RRE decoy in different positions, directed by the same promoter or by different promoters, were generated. Retroviral vectors containing tat22/37 and the RevM10 transdominant negative mutant were also constructed. Jurkat cells were transduced with the recombinant retroviruses to produce monoclonal and polyclonal cultures. In these cell lines the recombinant proviruses were correctly integrated and expression of the inserted genes was detected by Northern blot or RT-PCR analysis. However, infection of these cell lines with HIV-1 showed that none of these recombinant constructs inhibited virus replication at a high multiplicity of infection (MOI). At a low MOI, two cell clones containing tat22/37 and the RRE decoy in 3' position showed a long lasting protection against virus replication, in comparison to control cultures expressing tat22/37 or RRE alone. Combination of tat and rev mutants was ineffective in inhibiting HIV-1 replication at both low and high MOIs. At a low MOI, HIV-1 replication was efficiently blocked in two cell clones expressing the RevM10 mutant alone. These results show a synergic effect of anti-tat and anti-rev molecules when the RRE sequence is cloned 3' to tat22/37, suggesting the possibility of using this vector design to control HIV-1 replication.
Assuntos
Genes rev/genética , Genes tat/genética , Terapia Genética/métodos , Infecções por HIV/terapia , HIV-1/fisiologia , Replicação Viral , DNA Recombinante/genética , DNA Viral/genética , Regulação da Expressão Gênica , Vetores Genéticos , HIV-1/genética , Humanos , Células Jurkat , Retroviridae/genética , Transcrição GênicaRESUMO
It was previously shown that a tat mutant (tat22) where cysteine 22 is substituted by glycine behaves as a transdominant negative mutant in Jurkat T cells lytically or latently infected by HIV-1. In this study we demonstrate that tat22 controls HIV-1 replication in primary cells. This effect was observed both after in vitro infection of peripheral blood mononuclear cells (PBMCs) from normal donors and after reactivation of the latent infection in PBMCs from seropositive patients. The antiviral effect of tat22 was limited to conditions of low virus production. The use of tat22 may be promising for a gene therapy approach to AIDS during the asymptomatic phase of the disease allowing control of virus replication in infected cells and inhibition of virus spread to uninfected cells.
Assuntos
Produtos do Gene tat/genética , Terapia Genética/métodos , Infecções por HIV/imunologia , HIV-1/fisiologia , Linfócitos T/virologia , Replicação Viral , Infecções por HIV/terapia , Humanos , Mutação , Produtos do Gene tat do Vírus da Imunodeficiência HumanaRESUMO
Postoperative infections are an outstanding problem in a surgical department. We have been studying them from a clinical and experimental point of view has a long time. In this study we present a method standardisation of postoperative peritoneal lavage as prevention of surgical infections. Winstar mice, infected with intra peritoneal E. coli cultures, underwent peritoneal lavage with saline solution or sterile water. The results showed the right amount of solution and the exact administration of lavage according to grade of infection. Encouraged by this result we are going to test the efficacy of anti microbial agents for the postoperative peritoneal lavage.
Assuntos
Lavagem Peritoneal/normas , Cuidados Pós-Operatórios/métodos , Animais , Masculino , CamundongosRESUMO
Tat mutants (tat22, tat37 and tat22/37) were constructed in the transactivation domain, where cysteines at positions 22 or/and 37 were substituted with glycine and serine, respectively. These mutants were expressed either in a BK virus episomal vector or in the retroviral vector LXSN. Constitutive production of tat22 by Jurkat T cells in the context of both vectors blocked HIV-1 replication during lytic infection. Conversely, the tat37 mutant did not show any inhibitory activity and tat22/37 displayed a mild effect on HIV-1 infection only when expressed by the recombinant retrovirus. However, constitutive production of tat22/37 by the BK virus vector in Jurkat T cells chronically infected by HIV-1 was effective in blocking reactivation of viral replication induced by tumor necrosis factor-alpha or human herpesvirus-6. These results suggest that mutants in the transactivation domain of tat may be considered in designing alternative strategies to control HIV-1 replication and reactivation from latency during different phases of infection.
Assuntos
Cisteína/metabolismo , Genes tat , HIV-1/fisiologia , Ativação Viral/genética , Latência Viral/genética , Replicação Viral/genética , Sequência de Bases , Linhagem Celular , Genes Dominantes , HIV-1/genética , Humanos , Dados de Sequência Molecular , Mutação , Oligodesoxirribonucleotídeos , Ativação TranscricionalAssuntos
Proteínas de Escherichia coli , Produtos do Gene tat/genética , Genes tat/genética , Infecções por HIV/virologia , HIV-1/genética , Receptores de Superfície Celular , Animais , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Sequência de Bases , Células Quimiorreceptoras , Regulação Viral da Expressão Gênica/genética , Produtos do Gene nef/genética , Produtos do Gene rev/genética , Produtos do Gene tat/química , Produtos do Gene tat/fisiologia , Terapia Genética , Infecções por HIV/terapia , Repetição Terminal Longa de HIV/genética , HIV-1/fisiologia , Humanos , Proteínas de Membrana/genética , Proteínas de Membrana/metabolismo , Dados de Sequência Molecular , Ativação Transcricional/genética , Produtos do Gene nef do Vírus da Imunodeficiência Humana , Produtos do Gene rev do Vírus da Imunodeficiência Humana , Produtos do Gene tat do Vírus da Imunodeficiência HumanaRESUMO
A BK virus (BKV) expression vector, specific for human cells, was engineered to express antisense human immunodeficiency virus type 1 (HIV-1) tat cDNA (tat-AS) or a tat mutant in cysteine 22 (tat22). Cysteine residues in the cysteine-rich domain of tat are necessary for tat transactivation of the HIV-1 long terminal repeat (LTR). Both the AS tat and the tat mutant significantly inhibited transactivation by tat when assayed in cells cotransfected with an expression vector where the reporter gene for chloramphenicol acetyl transferase was driven by the HIV-1 LTR. Infection of Jurkat cell clones stably expressing tat22 (Jurkat/tat22) or tat-AS (Jurkat/tat-AS) with HIV-1 did not show differences in virus titer in comparison to HIV-1-infected control cells. However, in two Jurkat/tat22 cell clones, entrance of HIV-1 into latency was accelerated significantly and reactivation of HIV-1 from latency induced by tumor necrosis factor-alpha (TNF-alpha) or tat was blocked. These results suggest that, in a combined and integrated approach to the treatment of acquired immunodeficiency syndrome (AIDS), anti-tat genetic therapy could be successfully applied to maintain virus in latency, thereby extending the duration of the asymptomatic phase preceding full-blown AIDS.
Assuntos
Genes tat/genética , HIV-1/genética , Ativação Viral , Latência Viral , Vírus BK , Northern Blotting , Antígenos CD4/análise , Linhagem Celular Transformada , Produtos do Gene tat/genética , Vetores Genéticos , HIV-1/fisiologia , Humanos , Mutagênese Sítio-Dirigida , Mutação/genética , RNA Antissenso/genética , RNA Viral/análise , Transcrição Gênica/genética , Produtos do Gene tat do Vírus da Imunodeficiência HumanaAssuntos
Regulação Viral da Expressão Gênica , Produtos do Gene tat/genética , HIV-1/genética , Mutagênese Sítio-Dirigida , RNA Antissenso/genética , RNA Mensageiro/genética , RNA Viral/genética , Ativação Transcricional , Sequência de Aminoácidos , Vírus BK/genética , Sequência de Bases , Genes Dominantes , Genes tat , Vetores Genéticos , Repetição Terminal Longa de HIV/genética , HIV-1/fisiologia , Humanos , Dados de Sequência Molecular , RNA Antissenso/biossíntese , RNA Mensageiro/biossíntese , RNA Viral/biossíntese , Transfecção , Replicação Viral , Produtos do Gene tat do Vírus da Imunodeficiência HumanaRESUMO
A eukaryotic vector-host cell system is described where the additive transactivating effects of HIV-1 tat and adenovirus E1A on HIV-1 long terminal repeat (LTR) are exploited to increase expression of exogenous cDNAs. Human 143B and 293 cells, the latter constitutively producing E1A, were used as host cell lines. The bacterial gene chloramphenicol acetyltransferase (CAT) and the hepatitis B surface antigen (HBs-Ag) gene were employed as reporter genes inserted in pRPneoU3R, an episomal vector containing BK virus replication origin and early region, where cDNAs are expressed under control of HIV-1 LTR. The 293 cells were transformed by tat expression vectors to constitutively express tat. Stable cell clones of 293tat cells, constitutively expressing CAT after transformation with pRPneoU3R-CAT, show a CAT activity 600-fold higher than normal 293 transformed cells. CAT expression obtained in normal 293 cells can be transiently increased 10-fold by transfection by vectors expressing tat. The 293tat cells transformed by pRPneoU3R-HBs, an episomal vector expressing HBs-Ag from HIV LTR, yielded stable cell clones secreting HBs-Ag in the culture medium at a concentration up to 744 ng/ml or 44 ng/10(6) cells/24 h, 48-fold more than normal 293 cells. The use of this system for constitutive or inducible expression of sequences under control of HIV-1 LTR is discussed in view of possible applications for diagnostic, vaccinal and therapeutic purposes.
Assuntos
DNA/genética , Expressão Gênica , Produtos do Gene tat/biossíntese , Repetição Terminal Longa de HIV/genética , HIV-1/genética , Proteínas Oncogênicas Virais/biossíntese , Proteínas Precoces de Adenovirus , Linhagem Celular Transformada , Cloranfenicol O-Acetiltransferase/genética , Clonagem Molecular , Produtos do Gene tat/genética , Vetores Genéticos , Antígenos de Superfície da Hepatite B/genética , Humanos , Hibridização de Ácido Nucleico , Proteínas Oncogênicas Virais/genética , Plasmídeos , Mapeamento por Restrição , Ativação Transcricional , Transfecção , Produtos do Gene tat do Vírus da Imunodeficiência HumanaRESUMO
The efficacy of different therapies and vaccine preparations was assessed for treating or preventing herpetic ocular keratitis induced by experimental inoculation in rabbits with two HSV-1 variants that display different pathogenetic potential. Early administration of acyclovir (ACV) promoted fast healing and prevented neurologic involvements: alpha-interferon (alpha-IFN) was less efficient than ACV; combined therapy with both drugs increased the antiviral effects. In an attempt to prevent the disease, rabbits were vaccinated with a slightly pathogenic HSV-1 variant or with a secreted form of an engineered HSV-1 glycoprotein gB (gB-1s) and were subsequently challenged with a highly pathogenic HSV-1 variant. Immunization of rabbits with gB-1s was much more efficient than immunization with live virus in reducing the severity of herpetic keratitis and in preventing CNS disease.
Assuntos
Aciclovir/uso terapêutico , Interferon Tipo I/uso terapêutico , Ceratite Dendrítica/prevenção & controle , Simplexvirus/imunologia , Vacinas Virais , Animais , Terapia Combinada , Ceratite Dendrítica/terapia , Coelhos , Vacinação , Vacinas Atenuadas , Vacinas Sintéticas , Proteínas do Envelope Viral/imunologiaRESUMO
The herpes simplex virus type 1 (HSV-1) glycoprotein B (gB-1) gene, deleted of 639 nucleotides that encode the transmembrane anchor sequence and reconstructed with the extramembrane and intracytoplasmic domains, was cloned under control of the Rous sarcoma virus long terminal repeat in the episomal replicating vector pRP-RSV, which contains the origin of replication and early region of the human papovavirus BK as well as a cDNA for a mutant mouse dihydrofolate reductase that is resistant to methotrexate. gB-1 (0.15 to 0.25 pg per cell per 24 h) was constitutively secreted into the culture medium of pRP-RSV-gBs-transformed human 293 cells. Treatment of transformed cells with methotrexate at high concentrations (0.6 to 6 microM) increased gB-1 production 10- to 100-fold, because of an amplification of the episomal recombinant. Mice immunized with secreted gB-1 produced HSV-1- and HSV-2-neutralizing antibodies and were protected against HSV-1 lethal, latent, and recurrent infections. Constitutive expression of secreted gB-1 in human cells may establish a system to develop diagnostic material and a subunit vaccine for HSV infections.
Assuntos
Vírus BK/genética , Vetores Genéticos , Herpes Simples/imunologia , Imunização , Polyomavirus/genética , Simplexvirus/patogenicidade , Proteínas do Envelope Viral/imunologia , Animais , Southern Blotting , Feminino , Expressão Gênica , Genes Virais , Herpes Simples/prevenção & controle , Camundongos , Camundongos Endogâmicos BALB C , Hibridização de Ácido Nucleico , Plasmídeos , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/imunologia , Simplexvirus/genética , Proteínas do Envelope Viral/administração & dosagem , Proteínas do Envelope Viral/genética , Proteínas Estruturais Virais/genéticaRESUMO
The properties of pRP-c, a new vector for complementary DNA (cDNA) expression, are described. The vector contains the early region and replication origin of BK virus (BKV), a human papovavirus. Due to the presence of these BKV sequences, pRP-c replicates in human cells allowing amplification of inserted cDNAs. The promoter, intron and polyadenylation region for cDNA expression are separated by unique restriction sites and can therefore be individually excised and substituted with different transcription signals. Coding sequences of the bacterial genes for chloramphenicol-acetyl transferase (CAT) or neomycin phosphotransferase (neo) were inserted into the cDNA cloning site of pRP-c and expressed in human cells in transient assays or stable clones. In both cases expression of the inserted sequences was significantly more efficient than by using the integration vectors pSV2CAT and pSV2neo, demonstrating the advantages of episomal expression vectors in human cells. Possible uses of pRP-c to express viral and cellular cDNAs in human cells are discussed.
Assuntos
Vírus BK/genética , DNA Viral/biossíntese , Vetores Genéticos , Plasmídeos , Polyomavirus/genética , Southern Blotting , Células Cultivadas , Cloranfenicol O-Acetiltransferase/biossíntese , Clonagem Molecular , DNA/biossíntese , Enzimas de Restrição do DNA/farmacologia , Humanos , TransfecçãoRESUMO
The authors report 20 patients in whom a large number of dead or severely damaged yeast cells, supposedly Candida albicans yeasts, were the possible cause of chronic recurrent diarrhea and abdominal cramps. It is suggested that the presence of large numbers of these microorganisms in stools may be considered among the possible etiologies of diarrhea in the 'irritable bowel syndrome'. The possible source of these yeast-like cells, the causes of cell damage, and the mechanisms by which these organisms may induce diarrhea should be investigated.
Assuntos
Candidíase/diagnóstico , Diarreia/etiologia , Fezes/microbiologia , Adulto , Doença Crônica , Doenças Funcionais do Colo/etiologia , Feminino , Humanos , Masculino , Microscopia Eletrônica de Varredura , Pessoa de Meia-IdadeRESUMO
Analysis of factors determining replication of BK virus (BKV) episomal vectors in human cells showed that vector copy number was related to the level of BKV T antigen expression. T antigen was synthesized efficiently, as assessed by indirect immunofluorescence, in vector-transfected primary embryonic fibroblasts undergoing neoplastic transformation. Surprisingly, transfected continuous cell lines (143 B, HeLa and KB), kept under biochemical selection or tested in transient assays, produced negligible amounts or no T antigen, revealed only by a sensitive ELISA test, suggesting that in these cells vector amplification was under the control of cellular factors. Presence or absence of BKV late region sequences, BKV strain, orientation of the inserted genes and presence or absence of selection were not relevant for vector replication. Type of biochemical selection, however, was important, since BKV vectors containing the thymidine kinase gene replicated better than those containing the neo gene. Despite great variability, vector copy number increased in transfected clones of adenovirus 5-transformed 293 cells, in the absence of immunofluorescence detectable T antigen. These cells express adenovirus immediate early proteins E1A and E1B which may directly or indirectly activate BKV origin of replication.